Expression of factors activated by hypoxia, growth factor VEGF, its receptor, carbohydrase IX in tissue in papillary cancers and metastases
- 作者: Spirina L.V1,2, Malysheva K.S2, Chizhevskaya S.U1,2, Kondakova I.V1, Kovaleva I.V2
-
隶属关系:
- Tomsk National Research Medical Center
- Siberian State Medical University
- 期: 卷 18, 编号 6 (2020)
- 页面: 57-64
- 栏目: Articles
- URL: https://journals.eco-vector.com/1728-2918/article/view/113353
- DOI: https://doi.org/10.29296/24999490-2020-06-09
- ID: 113353
如何引用文章
详细
全文:
作者简介
L. Spirina
Tomsk National Research Medical Center; Siberian State Medical University
Email: spirinalvl@mail.ru
Leader Researcher, Professor. Tomsk National Research Medical Center of the Russian Academy of Sciences, Cancer Research Institute; Siberian State Medical University. Docent. Doctor of Medical Sciences Kooperativnaya str., 5, Tomsk, 634050, Russian Federation; Moskovsky trakt, 2, Tomsk, 634050, Russian Federation
K. Malysheva
Siberian State Medical University
Email: taraz-kr@mail.ru
Student Moskovsky trakt, 2, Tomsk, 634050, Russian Federation
S. Chizhevskaya
Tomsk National Research Medical Center; Siberian State Medical University
Email: sch@oncology.tomsk.ru
leading researcher; associate Professor of the Department of Oncology. Tomsk National Research Medical Center of the Russian Academy of Sciences, Cancer Research Institute; Siberian State Medical University. Doctor of medicine Kooperativnaya str., 5, Tomsk, 634050, Russian Federation; Moskovsky trakt, 2, Tomsk, 634050, Russian Federation
I. Kondakova
Tomsk National Research Medical Center
Email: kondakova@oncology.tomsk.ru
Head of Laboratory of Tumor Biochemistry. Tomsk National Research Medical Center of the Russian Academy of Sciences, Cancer Research Institute. Professor, Doctor of Medical Sciences Kooperativnaya str., 5, Tomsk, 634050, Russian Federation
I. Kovaleva
Siberian State Medical University
Email: irina.kovalyova.kovaleva@mail.ru
Student Moskovsky trakt, 2, Tomsk, 634050, Russian Federation
参考
- Klaus A., Fathi O., Tatjana T.W., Bruno N., Oskar K. Expression of Hypoxia-Associated Protein HIF-1a in Follicular Thyroid Cancer is Associated with Distant Metastasis. Patho-lOncol Res. 2018; 24 (2): 289-96. https://doi. org/10.1007/s12253-017-0232-4.
- Xing M. Molecular pathogenesis and mechanisms of thyroid cancer. Nat Rev Cancer. 2013; 13 (3): 184-99. https://doi. org/10.1038/nrc3431.
- Burrows N., Babur M., Resch J., Williams K.J., Brabant G. Hypoxia-inducible factor in thyroid carcinoma. J. Thyroid Res. 2011; 2011: 762905. https://doi. org/10.4061/2011/762905.
- Gimm O., Castellone M.D., Hoang-Vu C., Kebebew E. Biomarkers in thyroid tumor research: new diagnostic tools and potential targets of molecular-based therapy. J. Thyroid Res. 2011; 2011: 631593. https://doi. org/10.4061/2011/631593.
- Du Y, Zhu J., Chu B.F., Yang Y.P., Zhang S.L. MiR-548c-3p suppressed the progression of papillary thyroid carcinoma via inhibition of the HIF1a-mediated VEGF signaling pathway Eur. Rev. Med. Pharmacol. Sci. 2019; 6570-8. https://doi.org/10.26355/ eurrev_201908_18543.
- Lodewij k L., van Diest P, van der Groep P, TerHoeve N., Schepers A., Morreau J., Bonenkamp J., van Engen-van Grunsven A., Kruijff S., van Hemel B., Links T., Nieveen van Dijkum E., van Eeden S., Valk G., Borel Rinkes I., Vriens M. Expression of HIF-1a in medullary thyroid cancer identifies a subgroup with poor prognosis. Oncotarget. 2017; 8 (17): 28650-9. https://doi. org/10.18632/oncotarget.15622.
- Stanojevic B., Saenko V, Todorovic L., Petrovic N., Nikolic D., Zivaljevic V, Paunovic I., Nakashima M., Yamashita S., Dzodic R. Low VHL mRNA expression is associated with more aggressive tumor features of papillary thyroid carcinoma. PLoS One. 2014; 9 (12): e114511. https:// doi.org/10.1371/journal.pone.0114511.
- Todorovic L., Stanojevic B., Mandusic V, Petrovic N., Zivaljevic V, Paunovic I., Diklic A., Saenko V, Yamashita S. Expression of VHL tumor suppressor mRNA and miR-92a in papillary thyroid carcinoma and their correlation with clinical and pathological parameters. Med Oncol. 2018; 35 (2): 17. https://doi.org/10.1007/s12032-017-1066-3.
- Spirina L.V, Chizhevskaya S.Y, Kondakova I.V Expression of transcription and growth factors and the AKT/m-TOR signaling pathway components in papillary thyroid cancer. Problems of Endocrinology. 2018; 64 (4): 208-15. https://doi.org/10.14341/ probl9310
- Albadari N., Deng S., Li W The transcriptional factors HIF-1 and HIF-2 and their novel inhibitors in cancer therapy. Expert Opin Drug Discov. 2019; 14 (7): 667-82. https:// doi.org/10.1080/17460441.2019.1613370.
- Spirina L.V, Usynin E.A., Yurmazov Z.A., Slonimskaya E.M., Kondakova I.V Effect of Targeted Therapy With Pazopanib on Expression Levels of Transcription, Growth Factors and Components of AKT/m-TOR Signaling Pathway in Patients with Renal Cell Carcinoma. Asian Pac J. Cancer Prev. 2017; 18 (11): 2977-83.
- Takacova M., Bullova P, Simko V, Skvarkova L., Poturnajova M., Feketeova L., Babal P, Kivela A.J., Kuopio T., Kopacek J. , Pastorek J., Parkkila S., Pastorekova S. Expression pattern of carbonic anhydrase IX in Medullary thyroid carcinoma supports a role for RET-mediated activation of the HIF pathway. Am. J. Pathol. 2014;953-65. https://doi.org/10.10Wj. ajpath.2014.01.002.
- Vela-Gaxha Z., Shahini L., Manxhuka-Kerliu S. The Prognostic Role of Vascular Endothelial Growth Factor-A Expression in Thyroid Carcinomas. Folia Med (Plovdiv). 2019; 61 (1): 61-8. https://doi.org/10.2478/folmed-2018-0059.
- Gawin M., Kurczyk A., Stobiecka E., Frtczak K, , Polanska J,, Pietrowska M,, Widtak P,. Molecular Heterogeneity of Papillary Thyroid Cancer: Comparison of Primary Tumors and Synchronous Metastases in Regional Lymph Nodes by Mass Spectrometry Imaging. Endocr Pathol. 2019; 30: 250-61 https:// doi.org/10.1007/s12022-019-09593-2
- Baldini E., Tuccilli C., Arlot-Bonnemains Y, Chesnel F, Sorrenti S., De Vito C., Catania A., DArmiento E., Antonelli A., Fallahi P, Watutantrige-Fernando S., Tartaglia F, Barollo S., Mian C., Bononi M., Arceri S., Mascagni D., Vergine M., Pironi D., Monti M., Filippini A., Ulisse S. Deregulated expression of VHL mRNA variants in papillary thyroid cancer. Mol Cell Endocrinol. 2017; 443: 121-7. https://doi.org/10.10Wj. mce.2017.01.019.